Canada has been forced to abandon the first proposed clinical trials for a Covid-19 vaccine in the country after Beijing blocked the shipment from a Chinese company involved in the collaboration.
The Canadian government has now turned to a couple of American drug companies, signing agreements for 114 million doses of potential candidates to combat the coronavirus pandemic.
The Government had announced the partnership between the National Research Council of Canada or NRC and CanSino Biologics, headquartered in Tianjin, China, in May.
However, the NRC has said that CanSino no longer had the authority to ship the vaccine for trials to Canada. Those trials were to be held at the Canadian Centre for Vaccinology at Dalhousie University in Halifax, Nova Scotia, which had also shared its research expertise with the Chinese firm.
